Screening process
CA 2477309 A1 · Owner: Mayers, Carl Nicholas · Inventors: Mayers, Carl Nicholas; Rowe, Sonya Claire; Duffield, Melanie Lorraine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for identifying a vaccine candidate said method comprising selecting , a protein from the proteome of a target organism on the basis of a property selected from a biophysical property or the amino acid composition of that protein. For example, using this method a first set of data for a said property of a one or more vaccine antigens of a particular genus is collected and a control set of data for said property of one or more random proteins from the same genus is also collected. These datasets are then compared and statistical differences noted. The proteome of a target species may then be examined and one or more vaccine candidates selected from that proteome on the basis …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 25, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 25, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 25, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.